Showing 1 - 3 results of 3 for search 'Teresa Valdés-Delgado', query time: 0.03s Refine Results
  1. 1
    Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing

    Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing by Federico Argüelles-Arias, Teresa Valdés Delgado, Belén Maldonado Pérez, Jaime González Antuña, Luisa Castro Laria

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease

    Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-T... by Pilar Navajas Hernández, Samer Mouhtar el Halabi, Ana Caridad González Parra, Teresa Valdés Delgado, Belén Maldonado Pérez, Luisa Castro Laria, Cloé Charpentier, Federico Argüelles-Arias

    Published 2024-10-01
    Get full text
    Article
  3. 3
    High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease

    High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease by Jaime González-Antuña, Teresa Valdés-Delgado, Belén Maldonado-Pérez, María Belvis-Jiménez, Luisa Castro-Laria, Vicente Merino-Bohórquez, Miguel Ángel Calleja-Hernández, Paula Castro-Martínez, Cloe Charpentier, Federico Argüelles-Arias

    Published 2024-09-01
    Get full text
    Article

Search Tools: